Recall Z-2258-2012— Beckman Coulter Inc.

Class II · Terminated

Class II FDA medical device recall by Beckman Coulter Inc., initiated 2011-10-13, terminated 2012-08-23. It names 2 FDA 510(k) clearances: K042291, K023764. Product: UniCel DxI 600 Access Immunoassay Systems, Part Numbers: Dxl 600: A30260; Dxl 600 with spot B: A71460. The DxI Immunoassay System is an in vitro diagnostic device used for the quantitative, semi-quantitative or qualitative determination of various analyte concentrations found in human body fluids.. Reason: The recall was initiated because Beckman Coulter has received seven reports of a software anomaly for the UniCel Dxl Immunoassay Systems. If undetected, this anomaly may cause erroneous test results..

Recalling firm
Beckman Coulter Inc.
Classification
Class II
Status
Terminated
Initiated
2011-10-13
Terminated
2012-08-23
Firm location
Brea, CA, United States

510(k) clearances named in this recall

2 on FDA's record

K-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.

Product description

UniCel DxI 600 Access Immunoassay Systems, Part Numbers: Dxl 600: A30260; Dxl 600 with spot B: A71460. The DxI Immunoassay System is an in vitro diagnostic device used for the quantitative, semi-quantitative or qualitative determination of various analyte concentrations found in human body fluids.

Reason for recall

The recall was initiated because Beckman Coulter has received seven reports of a software anomaly for the UniCel Dxl Immunoassay Systems. If undetected, this anomaly may cause erroneous test results.

Data sourced from openFDA. This site is unofficial and independent of the FDA.